About
Cathera, Inc, the first Alembic portfolio company, developed the Phenom family of microcatheters optimized for intracranial navigation. Cathera was acquired by Medtronic in 2018. Palmera, Inc, a second Alembic portfolio company, is developing new therapeutic and novel products for the minimally invasive treatment of stroke that have the potential to improve outcome for patients that are currently treated, as well as widen the scope of patients that can benefit from therapy.
Technologies
Cloudflare DNSOutlookMicrosoft Office 365CloudFlare HostingWordPress.orgMobile FriendlyQuantcastRemoteIoT
Keywords
medical equipment manufacturingregulatory registrationmedical devicesmicrocatheter optimizationregulatory compliancecross-functional teamsmedical equipment and supplies manufacturingmedical technologyneurosciencelifesaving interventional proceduresmedical device developmentbiotechnologyhealthcareproduct quality improvementhealthcare technologyglobal manufacturingconcurrent engineeringb2btherapeutic productsneurovascular solutionsinterventional neuroradiologyminimally invasive stroke treatmentquality management systemintracranial navigationmicrocatheter manufacturingpatient careminimally invasive therapystroke treatmentneurovascular device innovationmedical device incubator
Company Information
- Employees24
- Founded2018
Location
627 National Ave, Mountain View, California, United States, 94043-2221
